GW Pharmaceuticals CEO after new drug launch: it’s ‘important to distinguish between what’s medicine and what’s not’ in cannabis

Now, physicians have a level of “assurance” that if they prescribe Epidiolex [GW Pharmaceutical’s CBD], they’re giving patients a federally-sanctioned, standardized form of medication, the CEO said. “We think it’s’ really important to distinguish between what is medicine and what is not.”

“They know exactly what is in it, they understand the dosing, they understand its interactions, its safety profile and which patients to use it.  So we believe that the Epidiolex responds absolutely to that need and that our future products can similarly respond to needs in other parts of the medical community.”

Original Article (CNBC):
GW Pharmaceuticals CEO after new drug launch: it’s ‘important to distinguish between what’s medicine and what’s not’ in cannabis 
Artwork Fair Use: Carol M. Highsmith

Caves all the way down

The whole fungus: civil

Leave a Reply